CNS Interim CFO receives 187 dividend-equivalent restricted stock units

Rhea-AI Filing Summary

Cohen & Steers, Inc. (CNS) reported a Form 4 transaction for its Interim CFO and SVP. On 11/20/2025, the officer acquired 187 shares of common stock at a price of $0. These shares represent dividend equivalent restricted stock units credited in connection with the company’s fourth quarter 2025 dividend on previously granted unvested restricted stock units from May 2023, January 2024, January 2025 and October 2025. After this transaction, the officer beneficially owns 26,205 shares of Cohen & Steers common stock directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Donohue Michael T.

Role Interim CFO, SVP

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	187	$0.00	--

Holdings After Transaction: Common Stock — 26,205 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Donohue Michael T.

(Last) (First) (Middle)

1166 AVENUE OF THE AMERICAS

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COHEN & STEERS, INC. [ CNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CFO, SVP

3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/20/2025		A		187(1)	A	$0	26,205	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's fourth quarter 2025 dividend and accrued to the reporting person on unvested restricted stock units granted in May 2023, January 2024, January 2025 and October 2025.

Remarks:

	/s/ Brian W. Heller, Attorney-in-Fact	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CNS report in this Form 4?

The filing reports that an officer of Cohen & Steers, Inc. (CNS) acquired 187 shares of common stock on 11/20/2025.

Who is the reporting person in this CNS Form 4 filing?

The reporting person is an officer of Cohen & Steers, Inc., serving as Interim CFO and Senior Vice President.

How many CNS shares does the officer own after this transaction?

Following the reported transaction, the officer beneficially owns 26,205 shares of Cohen & Steers common stock, held directly.

What is the nature of the 187 CNS shares acquired?

The 187 shares represent dividend equivalent restricted stock units credited in connection with the issuer's fourth quarter 2025 dividend on unvested restricted stock units.

Which prior CNS equity grants are tied to these dividend equivalent units?

The dividend equivalent restricted stock units are linked to unvested restricted stock units granted in May 2023, January 2024, January 2025 and October 2025.

Was there any sale of CNS stock in this Form 4 transaction?

No sale is reported; the Form 4 reflects an acquisition (A) of 187 shares of Cohen & Steers common stock.